JP2020105193A5 - - Google Patents

Download PDF

Info

Publication number
JP2020105193A5
JP2020105193A5 JP2020036331A JP2020036331A JP2020105193A5 JP 2020105193 A5 JP2020105193 A5 JP 2020105193A5 JP 2020036331 A JP2020036331 A JP 2020036331A JP 2020036331 A JP2020036331 A JP 2020036331A JP 2020105193 A5 JP2020105193 A5 JP 2020105193A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
antigen
antibody
composition according
binding fragment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020036331A
Other languages
English (en)
Japanese (ja)
Other versions
JP6893265B2 (ja
JP2020105193A (ja
Filing date
Publication date
Priority claimed from JP2016552595A external-priority patent/JP6673840B2/ja
Application filed filed Critical
Publication of JP2020105193A publication Critical patent/JP2020105193A/ja
Publication of JP2020105193A5 publication Critical patent/JP2020105193A5/ja
Priority to JP2021089717A priority Critical patent/JP7343547B2/ja
Application granted granted Critical
Publication of JP6893265B2 publication Critical patent/JP6893265B2/ja
Priority to JP2023139455A priority patent/JP7636487B2/ja
Priority to JP2025020415A priority patent/JP7842268B2/ja
Priority to JP2026049809A priority patent/JP2026102867A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020036331A 2014-02-21 2020-03-04 Il−4r拮抗薬の投与により喘息を処置または予防するための方法 Active JP6893265B2 (ja)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP2021089717A JP7343547B2 (ja) 2014-02-21 2021-05-28 Il-4r拮抗薬の投与により喘息を処置または予防するための方法
JP2023139455A JP7636487B2 (ja) 2014-02-21 2023-08-30 Il-4r拮抗薬の投与により喘息を処置または予防するための方法
JP2025020415A JP7842268B2 (ja) 2014-02-21 2025-02-12 Il-4r拮抗薬の投与により喘息を処置または予防するための方法
JP2026049809A JP2026102867A (ja) 2014-02-21 2026-03-25 Il-4r拮抗薬の投与により喘息を処置または予防するための方法

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201461943019P 2014-02-21 2014-02-21
US61/943,019 2014-02-21
EP14306413 2014-09-15
EP14306413.7 2014-09-15
US201462077669P 2014-11-10 2014-11-10
US62/077,669 2014-11-10
JP2016552595A JP6673840B2 (ja) 2014-02-21 2015-02-20 Il−4r拮抗薬の投与により喘息を処置または予防するための方法

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2016552595A Division JP6673840B2 (ja) 2014-02-21 2015-02-20 Il−4r拮抗薬の投与により喘息を処置または予防するための方法

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021089717A Division JP7343547B2 (ja) 2014-02-21 2021-05-28 Il-4r拮抗薬の投与により喘息を処置または予防するための方法

Publications (3)

Publication Number Publication Date
JP2020105193A JP2020105193A (ja) 2020-07-09
JP2020105193A5 true JP2020105193A5 (cg-RX-API-DMAC7.html) 2020-11-19
JP6893265B2 JP6893265B2 (ja) 2021-06-23

Family

ID=66624883

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020036331A Active JP6893265B2 (ja) 2014-02-21 2020-03-04 Il−4r拮抗薬の投与により喘息を処置または予防するための方法
JP2021089717A Active JP7343547B2 (ja) 2014-02-21 2021-05-28 Il-4r拮抗薬の投与により喘息を処置または予防するための方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2021089717A Active JP7343547B2 (ja) 2014-02-21 2021-05-28 Il-4r拮抗薬の投与により喘息を処置または予防するための方法

Country Status (2)

Country Link
JP (2) JP6893265B2 (cg-RX-API-DMAC7.html)
IL (2) IL247290B (cg-RX-API-DMAC7.html)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7608693B2 (en) * 2006-10-02 2009-10-27 Regeneron Pharmaceuticals, Inc. High affinity human antibodies to human IL-4 receptor
CN104039352A (zh) * 2011-11-01 2014-09-10 米迪缪尼有限公司 用于降低哮喘急性恶化的频率和严重性的方法
KR102502640B1 (ko) * 2012-08-21 2023-02-23 사노피 바이오테크놀로지 Il-4r 길항제의 투여에 의한 천식의 치료 또는 예방 방법

Similar Documents

Publication Publication Date Title
JP2025038127A5 (cg-RX-API-DMAC7.html)
JP2023052457A5 (cg-RX-API-DMAC7.html)
EP3703818B1 (en) Il-4r antagonist for use in a method for treating or preventing asthma
JP2021501169A5 (cg-RX-API-DMAC7.html)
JP2022530533A5 (cg-RX-API-DMAC7.html)
JP2017507139A5 (cg-RX-API-DMAC7.html)
JP6306588B2 (ja) Il−4rアンタゴニストを投与することにより喘息を処置又は予防するための方法
JP2023162343A5 (cg-RX-API-DMAC7.html)
JP2015527364A5 (cg-RX-API-DMAC7.html)
AU2020201327A1 (en) Methods for reducing exacerbation rates of asthma using benralizumab
JP2022530533A (ja) Il-33アンタゴニストを投与することにより喘息を治療するまたは予防するための方法
US20240360232A1 (en) Methods for treating chronic obstructive pulmonary disease (copd) by administering an il-4r antagonist
JP2024129140A5 (cg-RX-API-DMAC7.html)
JP2022541191A5 (cg-RX-API-DMAC7.html)
KR102337599B1 (ko) 벤랄리주맙을 이용하여 천식 환자에서 강제 호기량을 증가시키는 방법
JP2023505215A5 (cg-RX-API-DMAC7.html)
JP2023505215A (ja) Il-33アンタゴニストを投与することによりcopdを治療するための方法
RU2006113701A (ru) Лечение респираторных заболеваний антителами против рецептора il-2
JP2025501239A5 (cg-RX-API-DMAC7.html)
Tosca et al. Hyperthyroidism in a 15-year-old adolescent treated with Dupilumab for severe allergic asthma and atopic dermatitis
KR20220009967A (ko) 벤랄리주맙을 이용하여 강화 환자 집단의 만성 폐쇄성 폐 질환을 치료하는 방법
RU2021134810A (ru) Способы лечения или предупреждения астмы посредством введения антагониста il-33
RU2025128783A (ru) Способы лечения хронической обструктивной болезни легких (copd) путем введения антагониста il-4r
Piña et al. Etanercept as a possible trigger of fatal pulmonary fibrosis
RU2023120407A (ru) Способы лечения или предотвращения астмы посредством введения антагониста il-4r